Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 13, 2013

Primary Completion Date

October 8, 2014

Study Completion Date

October 8, 2014

Conditions

Gaucher Disease

Interventions

DRUG

velaglucerase alfa

15-60 U/kg, EOW

Trial Locations (5)

Hamamatsu University School of Medicine, Hamamatsu

Iwata City Hospital, Ōkubo

The Jikei University School of Medicine, Minato-ku

Chiba Children's Hospital, Chiba

Osaka City University Hospital, Osaka